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ABSTRACT
Background: Numerous transient effects of anesthesia on postoperative im-
mune status have been documented in the literature.
Objective: This study was performed to test the hypothesis that the effects on
neutrophil and T-cell populations differ with use of low-flow sevoflurane- and
desflurane-induced anesthesia during abdominal surgery.
Methods: Fifty adult patients (American Society of Anesthesiologists physical
tatus I or II) aged 20 to 60 years were recruited for the study. Patients were randomly
ssigned to one of two study groups. Anesthesia was induced using fentanyl, propofol, and
ecuronium. After intubation, patients in group 1 received sevoflurane, oxygen, and
itrous oxide at a flow rate of 6 L/min, and those in group 2 received desflurane, oxygen,
nd nitrous oxide at a flow rate of 6 L/min. Ten minutes after induction of anesthesia, the
ow rate was decreased to 1 L/min in both groups. Total leukocyte, lymphocyte, and
eutrophil counts, percentage of T helper lymphocytes (CD4), cytotoxic T lymphocytes
CD8), natural killer lymphocytes, and active T lymphocyte, CD4/CD8 ratio, and plasma
ortisol values were assessed before and at 2 and 24 hours after induction of anesthesia.
Results: In the desflurane group, at 2 hours after induction of anesthesia,
significant decrease was observed in the lymphocyte count, percentage of CD4
ells, and CD4/CD8 ratio, and a significant increase was noted in the neutrophil
ount and percentage of CD8 cells (P  0.05). At 24 hours after induction of
nesthesia, a significant increase was observed in the leukocyte and neutrophil
ounts, percentage of CD4 cells, and CD4/CD8 ratio (P  0.05). There was no
hange in the other parameters studied. In the sevoflurane group, a significant
ecrease was observed in the lymphocyte count and percentage of natural killer
ells. In addition, a significant increase was noted in the leukocyte and neutrophil
ounts at 24 hours after induction of anesthesia (P  0.01). The increase in the
eutrophil count in the desflurane group compared with that in the sevoflurane
roup was statistically significant (P  0.05).
Conclusions:With use of the low-flow anesthesia technique, compared with
esflurane, sevoflurane exerts minimal effects on neutrophil and T-cell populations,
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INTRODUCTION
Numerous transient effects of anesthesia on postoperative immune status have been
documented in the literature.1–6 Because infections are a major cause of perioperative
morbidity and mortality, prevention of instability of the immune system is impor-
tant. The extent of the immunologic response parallels the effects of the surgical
trauma and anesthesia.2,3 This impairment increases the risk of developing postop-
rative complications such as systemic inflammatory response syndrome, sepsis, and
ultiple-organ failure.2 Responsible mechanisms include lymphopenia, neutrophilia,
uppression of natural killer (NK) and T-lymphocyte subpopulations, dysfunction of
K, T, and B lymphocytes, blastogenic unresponsiveness to mitogenic agents,
ntibody-mediated lymphocyte cytotoxicity, and delayed hypersensitivity skin reac-
ions. Supplemental drugs administered preoperatively and blood transfusions may
esult in changes in T-lymphocyte subpopulations.4
The cell-mediated immune response is executed by cytotoxic T lymphoctes and
elper T cells with CD8 and CD4 surface markers, respectively. B lymphocytes are
unique immune system cells with CD9 surface markers, and are responsible for
ntibody production. Natural killer cells, which contain intracellular granules, pro-
uce direct cellular cytotoxicity. CD16 and CD56 molecules are used to identify NK
ells with the CD2CD3– phenotype, whereas the CD25 surface marker is unique to
ctivated T lymphocytes.5
Hemodynamic, endocrine, and hematologic interactions of the common volatile
nesthetic agents have been well documented.4–7 Cell-mediated immunity is sup-
ressed to a greater extent than is the humoral immune response.4,8,9
In the last decade, low-flow anesthetic delivery has been widely used in adult
atients. This anesthesia technique significantly reduces waste of expensive volatile
nesthetic agents and prevents air pollution.
Compared with all previously used volatile anesthetic agents, sevoflurane and
esflurane are less soluble in blood and tissues.10 Sevoflurane suppresses cell-mediated
mmunity to a lesser extent than the other agents do.11,12 Desflurane is considered the
deal agent for delivery of low-flow anesthetic because of its short wash-in period and,
hus, its rapidly stabilizing alveolar concentration.13 Because the concentration in
inspired gas can be titrated easily and rapidly, Hargasser et al14 have suggested that
esflurane is the volatile agent of choice for delivery of low-flow inhalation
nesthetic.The effects of desflurane and the low-flow anesthesia technique, how-
ver, have not yet been investigated. The objective of the present study was to
nvestigate and compare the effects of desflurane and sevoflurane on neutrophil
nd T-cell populations.
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Consent for this study was obtained from the ethics committee at our institution.
Fifty patients were recruited for the study. Inclusion criteria were fitness grade I or
II using the American Society of Anesthesiologists physical status classification, age
20 to 60 years, and scheduled elective upper or lower abdominal surgery. Patients
were randomly assigned to one of two treatment groups using a computer-generated
random number table (MedCalc version 10.1; MedCalc Software BVBA, Meriakerke,
Belgium). Exclusion criteria were presence of diabetes, renal or hepatic insufficiency,
malignant disease, cardiac disease, respiratory disorders, recent infections, or any
endocrine or metabolic dysfunction, history of taking immune system–modulating
drugs, and abnormal routine laboratory test results.
On the day before surgery, patients were informed about the procedure, and all
gave written consent. Patients were treated equally except for the inhalation anes-
thetic they were given. No premedication was administered. Electrocardiography,
pulse rate, peripheral oxygen saturation, systolic arterial pressure, diastolic arterial
pressure, and mean arterial pressure were all recorded. Inspired and expired oxygen
fractions, nitrous oxide (N2O), and end-tidal carbon dioxide values were continuously
monitored. Before induction of anesthesia, all patients received pure oxygen for 5
minutes. For induction, 1 to 2 mg propofol and 1 to 3 g/kg fentanyl were given
intravenously until paralysis of the eyelash reflex, followed by intravenous adminis-
tration of 0.1 mg/kg vecuronium; then orotracheal intubation was performed. For
maintenance, the volatile agents sevoflurane (Sevorane; Abbott Laboratories, Abbott
Park, Illinois) and desflurane (Suprane; Baxter Healthcare Corp., Deerfield, Illinois)
were used in groups 1 and 2, respectively. Ventilation parameters were adjusted so
that end-tidal carbon dioxide was 30 to 40 mm Hg (tidal volume, 7 to 10 mL/kg, and
respiratory frequency, 12 breaths/min).
In group 1 (n 25), at the beginning of anesthesia, 4 L/min N2O, 2 L/min oxygen
O2), and 2% to 2.5% sevoflurane in combination was given for 10 minutes.
15,16
Then 50%O2, 50% N2O, and 2.5% to 3 % sevoflurane was given as 1.5 minimal
alveolar concentration total fresh gas flow at 1 L/min using a vaporizer (model 19.3;
Dräger Medical GmbH, Lübeck, Germany).
In group 2 (n  25), at the beginning of anesthesia, 4 L/min N2O, 2 L/min O2,
nd 4% to 6% desfluran in combination was given for 10 minutes.15,16 Then 50%O2,
50% N2O, and 3% to 5% desflurane was given as 1 minimal alveolar concentration
otal fresh gas flow at 1 L/min using a vaporizer (Devapor; Dräger Medical GmbH).
Systolic, diastolic, and mean arterial pressures, pulse rate, peripheral O2 saturation,
and end-tidal gas values were measured before induction of anesthesia and during
surgery. After induction, these values were recorded every 5 minutes for the first 30
minutes of the operation, every 15 minutes to minute 90 of the operation, and every
half hour until completion of the operation. Volatile anesthesic concentrations were
also recorded in the samples obtained via a side-stream method and using infrared
analysis.9 In the respiratory circuit, peak levels of sevoflurane and desflurane were set
o 3% to 3.5% and 8% to 10%, respectively. Opioids are well-known immune system
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operatively.
In the termination phase of anesthesia, the vaporizer was turned off 10 to 15
minutes before the end of surgery, and low flow (50% O2 and 50% N2O) was
maintained at a rate of 1 L/min. With the recovery of spontaneous ventilation, 100%
O2 at a rate of 5 L/min for 5 to 10 minutes was administered before extubation.
17
Residual neuromuscular blockade was reversed via administration of 0.06 mg/kg
neostigmine and 0.02 mg/kg atropine. Blood loss and transfusions were recorded
intraoperatively. Calculation of blood loss was based on the amount measured in the
suction drain and the weight gain of the sponges. Patients who lost more than 500
mL blood and who received transfusions were excluded from the study. Postopera-
tively, all patients in both groups were observed for 24 hours to record hypertension,
hypotension, bradycardia, tachycardia, and hypoxemia (defined as peripheral O2
saturation 90%). A vital monitor (model PM 8040) and anesthetic device for
mechanical ventilation (Cato M33010) (both from Dräger GmbH) were used during
the study.
Thirty minutes before and at 2 and 24 hours after induction of anesthesia, 3 mL
peripheral venous blood was obtained from each patient and preserved in EDTA tubes
(Vacutainer; BD Biosciences, Franklin Lakes, New Jersey). Simultaneously, 3 mL
blood in conventional tubes was delivered to the laboratory in 20 minutes for
determination of cortisol concentration. Total leukocyte, lymphocyte, and neutrophil
counts, percentage of total T lymphocytes (CD3), B lymphocytes (CD19), helper T
lymphocytes (CD4), cytotoxic T lymphocytes (CD8), NK lymphoctes (CD16, 56),
and activated T lymphocytes (CD25), the CD4/CD8 ratio, and plasma cortisol
concentration were documented. Initial values were considered as those obtained 30
minutes before induction of anesthesia.
An HMX device (Beckman Coulter, Inc., Fullerton, California) was used for the
leukocyte, lymphocyte, and neutrophil counts. For determination of the lymphocyte
subgroups, 100 L blood sample was mixed with 15 L monoclonal antibodies. After
incubation for 30 minutes, lysing solution was added, and the mixture was incubated
for another 10 minutes in the dark, and subsequently was centrifuged at 1200 rpm
for 10 minutes. The precipitate was treated with phosphate-buffered saline solution
and centrifuged at 1200 rpm for another 10 minutes. Cytometry (FACSort Flow
Cytometer; BD Biosciences) was used to define T-lymphocyte subgroups. Two types
of antibody stains, fluorescein isothiocyanate (FITC) and phycoerythrin (PE), were
used: for the lymphocyte subgroups, CD3 FITC, CD4 PE, CD8 PE, CD 19 PE, CD25
FITC, and CD 16/56 PE antibodies, and for the control group, IgG1 and IgG2a
monoclonal antibodies. Plasma cortisol concentration was determined using a radio-
immunoassay kit (Immunotech; Beckman Coulter, Inc.).
Dependent variables were compared using the paired-sample t test, and indepen-
dent groups using the t test. Continuous variables are given as mean (SD), and
categorical variables as frequency. Statistical significance was considered at P  0.05.
tatistical analyses were performed using SPSS for Windows (version 10.0; SPSS, Inc.,
hicago, Illinois).
44
o
c
o
1
d
a
w
s
[
l
L. Pirbudak Cocelli et al.RESULTS
No statistical significance was noted between the demographic properties, operative
time, duration of anesthesia, and perioperative blood loss in the two groups (Table I).
Perioperatively, no hypertension, hypotension, bradycardia, or tachycardia was re-
corded according to pulse rate and mean arterial pressure. No patient received a blood
transfusion or had blood loss more than 500 mL; therefore, no patient was excluded
from the study. No patient was receiving ephedrine, -adrenergic blockers, or
antihypertensive drugs. End-tidal sevoflurane and desflurane concentrations did not
differ significantly within groups. Inspired total gas was maintained at greater than
92%, and inspired O2 concentration did not decrease to less than 30%. No loss
ccurred in total circulating gas volume. Total fentanyl, propofol, and vecuronium
onsumption was similar between groups (P  0.05).
In both groups, mean (SD) total leukocyte counts at 2 and 24 hours after induction
f anesthesia (9.43 [3.42]  10–3/L vs 9.87 [2.42]  10–3/L in group 1, and
1.83 [3.91]  10–3/L vs 12.42 [5.76]  10–3/L in group 2) were significantly
ifferent within groups (P  0.01). Similarly, neutrophil counts at 2 and 24 hours
fter induction (6.65 [3.32]  10–3/L vs 7.14 [2.13]  10–3/L in group 1, and
8.27 [3.9] 10–3/L vs 9.7 [5.5] 10–3/L in group 2) were significantly different
ithin groups (P  0.01). Neurophil count at postoperative hour 24 showed a
ignificant increase in group 2 (7.14 [2.13]  10–3/L) compared with group 1 (9.7
5.5]  10–3/L) (P  0.05). At 2 hours after induction, a significant increase in
Table I. Demographic data of patients receiving low-flow anesthetic using desflurane or
sevoflurane.*
Variable
Group 1 Sevoflurane
(n  25)
Group 2 Desflurane
(n  25)
Age, y 37.22 (11.2) 38.90 (10.3)
Sex, M/F 13/12 12/13
Height, cm 167.73 (6.81) 166.23 (6.55)
Weight, kg 73.53 (11.43) 72.12 (11.21)
ASA physical status I/II 16/9 17/8
Surgery, No. of patients
Cholecystectomy 8 7
Ureterolithotomy 5 6
Pyelolithotomy 7 8
Hysterectomy 5 4
Duration of surgery, min 76.74 (30.12) 79.63 (31.12)
Duration of anesthesia, min 88.91 (33.53) 90.44 (33.63)
Blood loss, mL 300.55 (85.65) 285.45 (95.53)
ASA, American Society of Anesthesiologists.
*Unless otherwise indicated, values are given as mean (SD).ymphocyte count was noted in group 2 (1.81 [0.62]  10–3/L vs 1.91 [0.73] 
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count in group 2 (2.56 [0.71]  10–3/L) when compared with group 1 (1.91
[0.73] 10–3/L) (P 0.05). At 24 hours, a significant decrease in both groups was
noted (1.91 [0.73]  10–3/L vs 1.37 [0.42]  10–3/L in group 1, and 2.56
[0.71]  10–3/L vs 1.63 [0.51]  10–3/L in group 2) (P  0.01) (Table II).
Cortisol concentrations were elevated in both groups at 2 hours after induction of
nesthesia (16.33 [5.96] g/dL vs 25.74 [11.23] g/dL in group 1, and 17.62 [3.63]
g/dL vs 25.81 [4.83] g/dL in group 2) (P  0.01). At 24 hours, values returned
to baseline preanesthesia levels in group 1, whereas a significant decrease in preop-
erative baseline levels was observed in group 2 (13.45 [7.87] g/dL vs17.62 [3.63]
g/dL) (P  0.05) (Table II).
At 24 hours after surgery, CD19 rates were significantly elevated in both groups
compared with rates at 2 hours (13.73% [4.61%] vs 10.72% [4.31%] in group 1, and
13.12% [4.92%] vs 9.12% [4.92%] in group 2) (P  0.01) (Table III).
The percentage of CD4 cells did not change in group 1. However, in group 1, a
significant decrease at 2 hours (31.93% [6.65%]) (P 0.05) and a significant increase
at 24 hours was documented after induction of anesthesia (39.52% [8.01%]) when
compared with baseline levels (36.41% [6.92%]) (P  0.01). In group 1, the
percentage of CD8 cells was similar, whereas in group 2, there was a significant
increase at the 2 hours after induction (26.31% [8.35%] vs 28.52% [8.13%) (P 
0.05). In group 1, the CD4/CD8 ratio showed no change at any time, whereas in
group 2, there was a significant decrease at 2 hours (1.22 [0.43]) (P  0.01) and an
increase over baseline at 2 hours and 24 hours after induction (1.51 [0.52] and 1.82
[0.72], respectively) (P  0.05).
In both groups, the percentage of CD16 and CD56 cells showed a statistically
insignificant increase at 2 hours. However, at 24 hours, the percentage of CD16 cells
had declined significantly when compared with baseline (17.76% [9.42%] vs 12.86%
[6.54%] in group 1, and 17.12% [7.42%] vs 11.42% [6.03%] in group 2) (P 
Table II. Total leukocyte, neutrophil, and lymphocyte counts and plasma cortisol values.*
Variable
Time Relative to Induction of Anesthesia
Group 1 Sevoflurane Group 2 Desflurane
30 Minutes Before 2 Hours After 24 Hours After 30 Minutes Before 2 Hours After 24 Hours After
eukocytes, 10–3/L 7.12 (2.33) 9.43 (3.42)† 9.87 (2.42)† 7.36 (2.12) 11.83 (3.91)† 12.42 (5.76)†
Neutrophils, 10–3/L 4.33 (2.45) 6.65 (3.32)† 7.14 (2.13)†,‡ 4.31 (1.96) 8.27 (3.9)† 9.7 (5.5)†,‡
Lymphocytes, 10–3/L) 1.81 (0.62)§ 1.91 (0.73)†,§ 1.37 (0.42)†,§ 2.28 (0.61) 2.56 (0.71)†,‡,§ 1.63 (0.51)†
Cortısol, g/dL 16.33 (5.96)† 25.74 (11.23)† 15.78 (7.12) 17.62 (3.63)†,§ 25.81 (4.83)† 13.45 (7.87)§
*Values are given as mean (SD).
†P  0.01, compared with initial values within groups.
‡P  0.05, compared with values between groups.
§P  0.05, compared with initial values within groups.0.01). Similarly, at 24 hours, the percentage of CD56 cells had declined significantly
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24.31% [6.73%] vs 16.23% [6.24%] in group 2) (P  0.01) (Table III).
Postoperatively, systolic, diastolic, and mean arterial pressures, pulse rate, and
eripheral O2 saturation values did not change markedly. No significant change was
observed in O2 saturation levels in the two groups (P  0.05, data not shown).
Postoperative nausea, vomiting, pruritus, and sedation were not significantly different
between the groups. No patient in either group was severely sedated, and no instances
of respiratory depression were observed.
DISCUSSION
Recently, studies of the effects of anesthetic agents on the immune system have gained
great popularity. Hemodynamic, endocrine, and hematologic interactions of the common
volatile anesthetic agents have been well documented,4,6,7 and cell-mediated immunity is
suppressed to a greater extent than is the humoral immune response.4,8,9 Anesthesia leads
o inhibition of cell-mediated immunity, which is temporary and reversible but with the
onsiderable postoperative complications of morbidity and mortality.18 Sevoflurane in-
terferes the least with immunity when used with the high-flow fresh gas anesthetic
technique.6,12,19 Effects of desflurane on the immune response have been rarely investi-
gated in the literature. Low-flow anesthesia has also been widely used in adult patients in
the last decade because of economic and ecologic concerns. However, we could not find
any study in the literature reporting use of desflurane or sevoflurane with the low-flow gas
anesthesia technique.
In a recent study, it was reported that reduced numbers of CD8 cells due to
surgical stress was most likely responsible for the increased risk of infection at 24
hours after surgery.20 Hori et al21 used 66% N2O plus 33% O2 and 0.5% to 1.0 %
Table III. Total B (CD19), T (CD3), T helper (CD4), cytotoxic T (CD8), natural killer
(CD16,56), and active T (CD25) lymphocyte values and CD4/CD8 ratio.*
Variable
Time Relative to Induction of Anesthesia
Group 1 Sevoflurane Group 2 Desflurane
30 Minutes Before 2 Hours After 24 Hours After 30 Minutes Before 2 Hours After 24 Hours After
CD19 10.21 (2.82) 10.72 (4.31)† 13.73 (4.61)† 9.42 (3.61) 9.12 (4.92)† 13.12 (4.92)†
CD3 62.21 (9.41) 62.81 (5.56) 65.63 (7.74) 66.21 (7.72) 65.42 (8.33) 68.94 (6.62)
CD4 35.77 (8.63) 35.01 (9.42) 35.22 (9.55) 36.41 (6.92)†,‡ 31.93 (6.65)† 39.52 (8.01)‡
CD8 24.38 (6.13) 26.14 (9.43) 24.35 (7.23) 26.31 (8.35)‡ 28.52 (8.13)‡ 24.42 (7.53)
D16 17.76 (9.42)† 18.22 (8.43) 12.86 (6.54)† 17.12 (7.42)† 18.92 (8.11) 11.42 (6.03)†
CD56 24.63 (8.65)† 27.62 (8.35) 19.13 (7.42)† 24.31 (6.73) 28.12 (7.31) 16.23 (6.24)†
CD25 11.96 (4.82) 10.23 (3.74) 12.21 (4.52) 10.41 (4.82) 9.94 (4.04) 12.12 (4.73)
CD4/8 ratio 1.61 (0.72) 1.52 (0.81) 1.64 (0.82) 1.51 (0.52)†,‡ 1.22 (0.43)† 1.82 (0.72)‡
*Values for the various lymphocytes are given as percent, and for time and CD4/8 ratio are given as mean (SD).
†P  0.05, compared with initial values within groups.
‡P  0.01, compared with initial values within groups.nflurane in a study in patients who had undergone neurosurgery. They concluded
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esthesia level at 1 to 2 hours after surgical incision, and CD8 and NK subpopulations
showed a tendency to increase. In the control group who underwent minor surgery
using the same anesthesia technique, however, no remarkable change was noted. Our
study results seem to parallel those of Hori et al21 insofar as the CD4 and CD8 cells
and the CD4/CD8 ratio at 2 hours after incision. The number of CD4 cells, decrease
in the CD4/CD8 ratio, and increase in percentage of CD8 cells were significant at 2
hours in the desflurane group, whereas the reverse was true in the sevoflurane group.
In the present study, immune suppression at 2 hours was similar to that reported by
Hori et al21; however, this suppression was minimal with sevoflurane at within-group
analysis.
A limited number of studies in humans are available that document long-term
anesthesia without surgery. In in vitro experiments using volatile anesthetic agents,
the number of peripheral lymphocytes tended to decrease due to apoptosis.22 How-
ver, alterations in the concentration of the agent and duration of anesthesia may lead
o different conclusions in clinical practice.
Volatile agents impose variable and complicated effects on lymphocytes and
eutrophils. In an in vitro study conducted by Hiroshi et al,8 isoflurane, compared
with sevoflurane, caused a higher percentage of apoptotic lymphocytes. Delogu et al20
reported an increased incidence of apoptosis of CD4 and CD8 lymphocytes at 24
hours after administration of isoflurane and fentanyl anesthesia.
Short-term anesthesia using a high concentration of sevoflurane increases lympho-
cytes and decreases neutrophils.11 Dagan and Segal23 documented that 2% to 6%
evoflurane caused peripheral lymphocyte apoptosis that was dose and time depen-
ent. In the same study, N2O was proved to block neutrophil activity and concen-
ration. In vivo data show that anesthesia and surgery tend to increase the number of
irculating neutrophils.24 In particular, surgical procedures performed with the
patient under general anesthesia affect the immune-competent cell concentrations to
a greater extent. The change usually is manifested as lymphopenia and neutrophilia.21
Suppression of lymphocytes is proportional to the dosage of the anesthetic agent and
the duration of anesthesia.25
In the present study, the circulating neutrophil count was elevated at 2 and 24
ours after induction of anesthesia in both the sevoflurane and desflurane groups. At
hours, lymphocytes were also increased in both groups, but significantly only in the
esflurane group (P  0.05). At 24 hours, the lymphocyte count declined signifi-
antly in both groups when compared with initial values. Our results support those
f Rem et al,22 Dagan and Segal,23 and Perttila and Salo.24
Sevoflurane proved nongenotoxic and had a minimal effect on immunity in a study
n a pediatric population who received short-term 2.5% to 3% sevoflurane anesthesia in
L of fresh gas.26 In our study, we were convinced that longer sevoflurane anesthesia (89
inutes) using a low-flow technique may be safe, with minimal immunologic adverse
ffects.
In an experimental study using sevoflurane, a 3% concentration in 6 L/min freshas flow and a 40-minute single application per week for 3 weeks resulted in a
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study, sevoflurane had no effect on the percentage of lymphocyte subpopulations in
the spleen leukocyte composition.9
In a similar study, Puig et al27 reported a significant increase in lymphocytes,
decreased CD19 ratio in spleen composition, and increased CD4 cell count. The effect
of sevoflurane on T lymphocytes in that study corroborates our results.
In addition to the volatile agents, intravenously administered anesthetics may have
immunosuppressive interactions at high dosages and lengthy applications, which may
be secondary to increased cortisol concentration, blockade of NK cell activity,
decreased CD4 cell count, and/or lymphocyte proliferation.28,29
Costa et al4 documented a perioperative increase in cortisol concentration and
decreased CD4 cell counts during surgery with the patient under general anesthesia.
This explains the postoperative immunosuppression. CD8 and CD16 cells were not
affected to the same degree. We measured the cortisol concentration to evaluate the
role of neuroendocrine response on immunity. Our study was in concordance with the
relevant studies in the literature.
The CD4/CD8 ratio is a widely used measure of immunosuppression. Our levels
were similar to those of Hori et al21 and Costa et al.4 However, in the sevoflurane
group, CD4 and CD8 cell counts and the CD4/CD8 ratio showed little difference
when compared with the desflurane group.
It should be noted that due to methodologic imperfections such as lack of blinding
and preliminary nature, the results of our study may be limited.
CONCLUSIONS
In this preliminary report of the effects of the low-flow anesthesia technique on
neutrophil and T-cell populations during abdominal surgery, sevoflurane seemed to
have less effect than did desflurane. There is an evident need for further studies to
assess the clinical significance of these effects on the immune system in terms of
infection and length of hospital stay.
ACKNOWLEDGMENTS
The authors thank Dr. Karakurum for his contributions in the writing of the
manuscript and Dr. Tuzcuoglu, medical biologist, for his assistance in data collection
and interpretation. Drs. Pirbudak Cocelli, Ugur, and Karadasli all contributed to the
literature search, figure creation, study design, data collection, data interpretation,
and writing of the manuscript.
CONFLICTS OF INTEREST
The authors have indicated that they have no conflicts of interest regarding the
content of this article.
REFERENCES
1. Hunter JD. Effects of anaesthesia on the human immune system. Hosp Med. 1999;60:658–663.
49
1
1
1
1
1
1
1
1
1
1
Current Therapeutic Research2. Wakefield CH, Carey PD, Foulds S, et al. Changes in major histocompatibility complex class
II expression in monocytes and T cells of patients developing infection after surgery. Br J Surg.
1993;80:205–209.
3. Schilling T, Kozian A, Kretzschmar M, et al. Effects of propofol and desflurane anaesthesia on
the alveolar inflammatory response to one-lung ventilation. Br J Anaesth. 2007;99:368–375.
4. Costa A, Benedetto V, Ricci C, et al. Endocrine, hematological and immunological changes in
surgical patients undergoing general anesthesia. Ital J Surg Sci. 1989;19:41–49.
5. Abbas AK, Lichtman AH, Pober JS. General properties of immune responses. In: Cellular and
Molecular Immunology. 5th ed. Philadelphia, Pa: WB Saunders Co; 1991:4–16.
6. Erol A, Reisli R, Reisli I, et al. Effects of desflurane, sevoflurane and propofol on phagocytosis
and respiratory burst activity of human polymorphonuclear leucocytes in bronchoalveolar
lavage. Eur J Anaesthesiol. 2009;26:150–154.
7. Isik Y, Goksu S, Kocoglu H, Oner U. Low flow desflurane and sevoflurane anaesthesia in
children. Eur J Anaesthesiol. 2006;23:60–64.
8. Matsuoka H, Kurosawa S, Horinouchi T, et al. Inhalation anesthetics induce apoptosis in
normal peripheral lymphocytes in vitro. Anesthesiology. 2001;95:1467–1472.
9. Elena G, Amerio N, Ferrero P, et al. Effects of repetitive sevoflurane anaesthesia on immune
response, select biochemical parameters and organ histology in mice. Lab Animal. 2003;37:
193–203.
0. Eger EI II. New inhaled anesthetics. Anesthesiology. 1994;80:906–922.
1. Morisaki H, Aoyama Y, Shimada M, et al. Leucocyte distribution during sevoflurane anaes-
thesia. Br J Anaesth. 1998;80:502–503.
2. Schneemilch CE, Hachenberg T, Ansorge S, et al. Effects of different anaesthetic agents on
immune cell function in vitro. Eur J Anaesthesiol. 2005;22:616–623.
3. Hargasser SH, Mielke LL, Entholzner EK, et al. Experiences with the new inhalational agents
in low-flow anesthesia and closed-circuit technique: monitoring and technical equipment. Appl
Cardiopulm Pathophysiol. 1995;5(Suppl 2):47–57.
4. Hargasser S, Hipp R, Breinbauer B, et al. A lower solubility recommends the use of desflurane
more than isoflurane, halothane, and enflurane under low-flow conditions. J Clin Anesth.
1995;7:49–53.
5. Baum J, Berghoff M, Stanke HG, et al. Low-flow anesthesia with desflurane [in German].
Anaesthesist. 1997;46:287–293.
6. McCarthy L, Wetzel M, Sliker JK, et al. Opioids, opioid receptors, and immune response.
Drug Alcohol Depend. 2001;62:111–123.
7. Xie G, Jiang H. Clinical study of desflurane on low flow anesthesia compared with sevoflurane
and enflurane. Chin Med J. 1997;110:707–710.
8. Chen JE, Zheng ZX, Wang SH, Chen QH. Influence of operation under epidural anesthesia
on peripheral T lymphocyte subsets. Chin Med J. 1991;104:194–197.
9. Tyther R, Halligan M, Wang J. Effects of chronic occupational exposure to anaesthetic
gases on the rate of neutrophil apoptosis among anesthetists. Eur J Anaesthesiol. 2002;19:
604–608.
20. Delogu G, Moretti S, Antonucci A, et al. Apoptosis and surgical trauma: dysregulated
expression of death and survival factors on peripheral lymphocytes. Arch Surg. 2000;135:1141–
1147.
21. Hori Y, Ibuki T, Hosokawa T, Tanaka Y. The effects of neurosurgical stress on peripheral
lymphocyte subpopulations. J Clin Anesth. 2003;15–18.
22. Rem J, Brandt MR, Kehlet H. Prevention of postoperative lymphopenia and granulocytosis by
epidural analgesia. Lancet. 1980;1:283–284.
50
22
2
v
G
L. Pirbudak Cocelli et al.23. Dagan D, Segal S. Effect of anesthesia on the immune system suppression of the immunogenic
capacity of macrophages and lymphocyte transformation. Immunol Invest. 1989;18:975.
24. Perttila J, Salo M. Granulocyte microbicidal function in patients undergoing major abdominal
surgery under balanced anaesthesia. Acta Anaesthesiol Scand. 1987;31:100–103.
25. Nakagawara M, Takeshige K, Takamatsu J, et al. Inhibition of superoxide production and
Ca2 mobilization in human neutrophils by halothane, enflurane and isoflurane. Anesthesiol-
ogy. 1986;64:412.
26. Krause T, Scholz J, Jansen L, et al. Sevoflurane anaesthesia does not induce the formation of
sister chromatid exchanges in peripheral blood lymphocytes of children. Br J Anaesth. 2003;
90:233–235.
7. Puig NR, Ferrero P, Bay ML, et al. Effects of sevoflurane general anaesthesia: immunological
studies in mice. Int Immunopharmacol. 2001;2:95–104.
8. Welters ID, Menzebach A, Goumon Y, et al. Morphine suppresses complement receptor
expression, phagocytosis and respiratory burst in neutrophils by a nitric oxide and mu (3)
opiate receptor-dependent mechanism. J Immunol. 2000;111:139–145.
9. Jacobs R, Karst M, Scheinchen D, et al. Effects of fentanyl on cellular immune functions in
man. Int J Immunopharmacol. 1999;21:445–454.
Address correspondence to: Mete Gurol Ugur, MD, Gaziantep Uni-
ersitesi, Tip Fakultesi, Kadin Hastaliklari ve Dogum Poliklinigi, Sahinbey 27090,
aziantep, Turkey. E-mail: metegurolugur@hotmail.com
51
